Schroder Investment Management Group Acquires 463 Shares of Chemed Co. (NYSE:CHE)

Schroder Investment Management Group increased its holdings in shares of Chemed Co. (NYSE:CHEFree Report) by 1.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 45,291 shares of the company’s stock after purchasing an additional 463 shares during the quarter. Schroder Investment Management Group owned 0.30% of Chemed worth $23,906,000 as of its most recent filing with the SEC.

Several other hedge funds have also recently bought and sold shares of CHE. UMB Bank n.a. increased its position in shares of Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Atala Financial Inc acquired a new position in Chemed in the 4th quarter worth $29,000. CBIZ Investment Advisory Services LLC increased its holdings in Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company’s stock worth $30,000 after purchasing an additional 22 shares in the last quarter. Trust Co. of Vermont acquired a new stake in shares of Chemed in the 4th quarter valued at about $34,000. Finally, Tortoise Investment Management LLC lifted its holdings in shares of Chemed by 77.3% in the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company’s stock valued at $41,000 after purchasing an additional 34 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CHE. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a report on Friday, March 7th. Royal Bank of Canada raised their price target on shares of Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th.

View Our Latest Research Report on Chemed

Insider Activity at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now owns 102,679 shares in the company, valued at $60,957,441.93. This represents a 1.91 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 3.32% of the company’s stock.

Chemed Trading Down 0.7 %

Shares of CHE stock opened at $614.41 on Thursday. The firm’s fifty day moving average price is $577.76 and its two-hundred day moving average price is $567.62. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $639.61. The firm has a market capitalization of $8.99 billion, a P/E ratio of 31.05, a PEG ratio of 2.15 and a beta of 0.43.

Chemed Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were issued a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 annualized dividend and a yield of 0.33%. Chemed’s payout ratio is presently 10.05%.

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.